Australian company Microbio has been awarded a Federal Government Accelerating Commercialisation Grant to commercialise a new diagnostic assay to rapidly identify 26 of the most common pathogens that cause bloodstream infections and sepsis. The InfectID-Blood Stream Infection (BSI) diagnostic
assay is a real-time Polymerase Chain Reaction (PCR) identifies the
pathogen causing the infection in about two hours to enable patients to be
treated with targeted antimicrobials in a timely manner. Sepsis kills around 11 million people around the world
each year. | https://microbio.com.au/news-and-events/
"Great ideas, research and innovation can come from anyone – so often the best ideas do not have a voice. IdeaSpies provides a platform for people to share ideas that create a better world"
IdeaSpies
Matt Levy
Jonathan Chrimes